Published in J Antimicrob Chemother on April 03, 2013
Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. Biomed Res Int (2014) 2.34
First report of metallo-β-lactamase NDM-5-producing Escherichia coli in Japan. Antimicrob Agents Chemother (2014) 1.13
blaNDM-5 carried by an IncX3 plasmid in Escherichia coli sequence type 167. Antimicrob Agents Chemother (2014) 1.12
Molecular Characterization by Using Next-Generation Sequencing of Plasmids Containing blaNDM-7 in Enterobacteriaceae from Calgary, Canada. Antimicrob Agents Chemother (2015) 1.04
Klebsiella pneumoniae ST147 coproducing NDM-7 carbapenemase and RmtF 16S rRNA methyltransferase in Minnesota. J Clin Microbiol (2014) 1.00
Molecular epidemiology of NDM-1-producing Enterobacteriaceae and Acinetobacter baumannii isolates from Pakistan. Antimicrob Agents Chemother (2014) 0.95
A novel New Delhi metallo-β-lactamase variant, NDM-14, isolated in a Chinese Hospital possesses increased enzymatic activity against carbapenems. Antimicrob Agents Chemother (2015) 0.91
Biochemical analysis of metallo-β-lactamase NDM-3 from a multidrug-resistant Escherichia coli strain isolated in Japan. Antimicrob Agents Chemother (2014) 0.91
Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability. J Antimicrob Chemother (2014) 0.87
Dissemination of NDM metallo-β-lactamase genes among clinical isolates of Enterobacteriaceae collected during the SMART global surveillance study from 2008 to 2012. Antimicrob Agents Chemother (2014) 0.86
New Delhi Metallo-β-Lactamase-Mediated Carbapenem Resistance: Origin, Diagnosis, Treatment and Public Health Concern. Chin Med J (Engl) (2015) 0.86
Structural basis for carbapenem-hydrolyzing mechanisms of carbapenemases conferring antibiotic resistance. Int J Mol Sci (2015) 0.86
Identification of an NDM-5-producing Escherichia coli Sequence Type 167 in a Neonatal Patient in China. Sci Rep (2016) 0.85
Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health. BMC Microbiol (2017) 0.83
Further Spread of bla NDM-5 in Enterobacteriaceae via IncX3 Plasmids in Shanghai, China. Front Microbiol (2016) 0.83
NDM-12, a novel New Delhi metallo-β-lactamase variant from a carbapenem-resistant Escherichia coli clinical isolate in Nepal. Antimicrob Agents Chemother (2014) 0.83
Characterization of Carbapenem-Resistant Enterobacteriaceae with High Rate of Autochthonous Transmission in the Arabian Peninsula. PLoS One (2015) 0.83
Identification of a novel NDM variant, NDM-13, from a multidrug-resistant Escherichia coli clinical isolate in Nepal. Antimicrob Agents Chemother (2015) 0.82
Outbreak of NDM-1-producing Klebsiella pneumoniae ST76 and ST37 isolates in neonates. Eur J Clin Microbiol Infect Dis (2016) 0.80
Dissemination of clonal complex 2 Acinetobacter baumannii strains co-producing carbapenemases and 16S rRNA methylase ArmA in Vietnam. BMC Infect Dis (2015) 0.79
Rapid detection of New Delhi metallo-β-lactamase gene and variants coding for carbapenemases with different activities by use of a PCR-based in vitro protein expression method. J Clin Microbiol (2014) 0.77
Distribution and Relationships of Antimicrobial Resistance Determinants among Extended-Spectrum-Cephalosporin-Resistant or Carbapenem-Resistant Escherichia coli Isolates from Rivers and Sewage Treatment Plants in India. Antimicrob Agents Chemother (2016) 0.77
Emerging Carbapenem-Resistant Pseudomonas aeruginosa Isolates Carrying blaIMP Among Burn Patients in Isfahan, Iran. Arch Trauma Res (2016) 0.75
Emergence of Klebsiella pneumoniae ST273 Carrying blaNDM-7 and ST656 Carrying blaNDM-1 in Manila, Philippines. Microb Drug Resist (2016) 0.75
Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa. BMC Infect Dis (2016) 0.75
First Indian report of IncX3 plasmid carrying blaNDM-7 in Escherichia coli from bloodstream infection: potential for rapid dissemination. New Microbes New Infect (2017) 0.75
Plasmid-Mediated Novel blaNDM-17 Gene Encoding a Carbapenemase with Enhanced Activity in a Sequence Type 48 Escherichia coli Strain. Antimicrob Agents Chemother (2017) 0.75
Genetic characterization of blaNDM-harboring plasmids in carbapenem-resistant Escherichia coli from Myanmar. PLoS One (2017) 0.75
Vaccination against classical influenza in health-care workers: self-protection and patient protection. Dtsch Arztebl Int (2009) 2.53
NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother (2011) 2.40
Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother (2011) 2.26
Trimeric autotransporter adhesins: variable structure, common function. Trends Microbiol (2006) 2.02
DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect Immun (2005) 1.97
Bartonella adhesin a mediates a proangiogenic host cell response. J Exp Med (2004) 1.84
The Presentation, Diagnosis, and Treatment of Sexually Transmitted Infections. Dtsch Arztebl Int (2016) 1.77
Molecular analysis of fusidic acid resistance in Staphylococcus aureus. Mol Microbiol (2003) 1.76
Multidrug-resistant organisms detected in refugee patients admitted to a University Hospital, Germany June‒December 2015. Euro Surveill (2016) 1.54
Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances. Antimicrob Agents Chemother (2008) 1.51
Bartonella spp.: throwing light on uncommon human infections. Int J Med Microbiol (2010) 1.50
Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease. J Clin Microbiol (2006) 1.45
Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials (2005) 1.41
Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001. Int J Antimicrob Agents (2004) 1.33
Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS One (2010) 1.29
Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores. Gastroenterology (2007) 1.29
Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus. Int J Med Microbiol (2007) 1.29
The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother (2008) 1.26
Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis (2010) 1.24
Evaluation of the BD GeneOhm StaphSR assay for detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from spiked positive blood culture bottles. J Clin Microbiol (2009) 1.23
Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection. PLoS One (2008) 1.22
Treatment with tigecycline of recurrent urosepsis caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol (2007) 1.19
Analysis of a novel insect cell culture medium-based growth medium for Bartonella species. Appl Environ Microbiol (2008) 1.18
Structure of the head of the Bartonella adhesin BadA. PLoS Pathog (2008) 1.17
Prevalence of Bartonella henselae and Borrelia burgdorferi sensu lato DNA in ixodes ricinus ticks in Europe. Appl Environ Microbiol (2010) 1.15
Rapid identification of Staphylococcus aureus in blood cultures by a combination of fluorescence in situ hybridization using peptide nucleic acid probes and flow cytometry. J Clin Microbiol (2005) 1.14
Infection of human CD34+ progenitor cells with Bartonella henselae results in intraerythrocytic presence of B. henselae. Blood (2005) 1.12
Integrated detection of extended-spectrum-beta-lactam resistance by DNA microarray-based genotyping of TEM, SHV, and CTX-M genes. J Clin Microbiol (2009) 1.12
Hemin binding, functional expression, and complementation analysis of Pap 31 from Bartonella henselae. J Bacteriol (2003) 1.09
Orthopoxvirus infection transmitted by a domestic cat. J Am Acad Dermatol (2006) 1.04
Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2005) 1.04
Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology. Dtsch Arztebl Int (2012) 1.03
The head of Bartonella adhesin A is crucial for host cell interaction of Bartonella henselae. Cell Microbiol (2008) 1.01
Surface-associated motility, a common trait of clinical isolates of Acinetobacter baumannii, depends on 1,3-diaminopropane. Int J Med Microbiol (2012) 0.98
Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus. Infect Immun (2007) 0.97
Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care--prevalence and risk factors. Int J Med Microbiol (2013) 0.96
Analysis of Bartonella adhesin A expression reveals differences between various B. henselae strains. Infect Immun (2006) 0.95
Trimeric autotransporter adhesin-dependent adherence of Bartonella henselae, Bartonella quintana, and Yersinia enterocolitica to matrix components and endothelial cells under static and dynamic flow conditions. Infect Immun (2011) 0.91
Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice. Exp Transl Stroke Med (2011) 0.91
Bartonella quintana variably expressed outer membrane proteins mediate vascular endothelial growth factor secretion but not host cell adherence. Infect Immun (2006) 0.89
Unusual trafficking pattern of Bartonella henselae -containing vacuoles in macrophages and endothelial cells. Cell Microbiol (2005) 0.88
Bartonella vinsonii subsp. berkhoffii and Bartonella henselae as potential causes of proliferative vascular diseases in animals. Med Microbiol Immunol (2012) 0.88
Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease. J Clin Microbiol (2008) 0.88
Proteomic analysis of the bacterial pathogen Bartonella henselae and identification of immunogenic proteins for serodiagnosis. Proteomics (2009) 0.88
Rapid screening for Streptococcus agalactiae in vaginal specimens of pregnant women by fluorescent in situ hybridization. J Clin Microbiol (2003) 0.87
Peroxisome proliferator-activated receptor γ-induced T cell apoptosis reduces survival during polymicrobial sepsis. Am J Respir Crit Care Med (2011) 0.86
Rapid and efficient transposon mutagenesis of Bartonella henselae by transposome technology. Gene (2003) 0.85
Performance of two MALDI-TOF MS systems for the identification of yeasts isolated from bloodstream infections and cerebrospinal fluids using a time-saving direct transfer protocol. Med Microbiol Immunol (2013) 0.85
Bartonella henselae trimeric autotransporter adhesin BadA expression interferes with effector translocation by the VirB/D4 type IV secretion system. Cell Microbiol (2012) 0.84
In vitro activity of eight oral cephalosporins against Borrelia burgdorferi. Int J Antimicrob Agents (2003) 0.84
Burden of carbapenem-resistant organisms in the Frankfurt/Main Metropolitan Area in Germany 2012/2013 - first results and experiences after the introduction of legally mandated reporting. BMC Infect Dis (2014) 0.83
Hypoxia-inducible factor 1-regulated lysyl oxidase is involved in Staphylococcus aureus abscess formation. Infect Immun (2013) 0.83
Does a feline leukemia virus infection pave the way for Bartonella henselae infection in cats? J Clin Microbiol (2010) 0.83
Influence of nebivolol and metoprolol on inflammatory mediators in human coronary endothelial or smooth muscle cells. Effects on neointima formation after balloon denudation in carotid arteries of rats treated with nebivolol. Cell Physiol Biochem (2007) 0.82
Adhesins of Bartonella spp. Adv Exp Med Biol (2011) 0.82
Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi. Antimicrob Agents Chemother (2004) 0.82
Diagnosis and treatment of Staphylococcus aureus infections of the skin and mucous membranes. J Dtsch Dermatol Ges (2011) 0.81
Evaluation of Mycobacterium tuberculosis drug susceptibility in clinical specimens from Nigeria using genotype MTBDRplus and MTBDRsl assays. Eur J Microbiol Immunol (Bp) (2013) 0.81
Diminished phagocytosis-induced cell death (PICD) in neonatal monocytes upon infection with Escherichia coli. Pediatr Res (2008) 0.80
Analysis of the BadA stalk from Bartonella henselae reveals domain-specific and domain-overlapping functions in the host cell infection process. Cell Microbiol (2011) 0.79
Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs. Antimicrob Agents Chemother (2009) 0.78
Presumed tuberculosis-induced retinal vasculitis, diagnosed with positron emission tomography (18F-FDG-PET/CT), aspiration biopsy, and culture. Ocul Immunol Inflamm (2010) 0.78
[Staphylococcal infections of the skin and mucous membranes. Guideline of the German Dermatologic Society, Study Group of Dermatologic Infectiology]. J Dtsch Dermatol Ges (2005) 0.77
Biogenesis of Afipia-containing phagosomes in non-professional phagocytes. Microbes Infect (2007) 0.77
Antimicrobial activities of trimethoprim/sulfamethoxazole, 5-iodo-2'-deoxyuridine and rifampicin against Staphylococcus aureus. Int J Antimicrob Agents (2010) 0.77
Novel promising linezolid analogues: rational design, synthesis and biological evaluation. Eur J Med Chem (2013) 0.77
Host cell modulation by human, animal and plant pathogens. Int J Med Microbiol (2004) 0.77
A validation protocol and evaluation algorithms to determine compatibility of cell therapy product matrices in microbiological testing. Cell Tissue Bank (2014) 0.77
[Prevalence of haemotropic Mycoplasma spp., Bartonella spp. and Anaplasma phagocytophilum in cats in Berlin/Brandenburg (Northeast Germany)]. Berl Munch Tierarztl Wochenschr (2012) 0.77
Adhesion and host cell modulation: critical pathogenicity determinants of Bartonella henselae. Parasit Vectors (2011) 0.77
Author's reply: Is there a need for special treatment of refugees at hospital admission? Euro Surveill (2016) 0.77
Use of Bartonella adhesin A (BadA) immunoblotting in the serodiagnosis of Bartonella henselae infections. Int J Med Microbiol (2008) 0.76
Acute oxygen-sensing mechanisms. N Engl J Med (2006) 0.76
Comments on Point:Counterpoint "Positive effects of intermittent hypoxia (live high:train low) on exercise performance are/are not mediated primarily by augmented red cell volume". J Appl Physiol (1985) (2005) 0.75
Haemanthus coccineus extract and its main bioactive component narciclasine display profound anti-inflammatory activities in vitro and in vivo. J Cell Mol Med (2015) 0.75
Dissemination of a localized cutaneous infection with Mycobacterium chelonae under immunosuppressive treatment. Arch Dermatol (2007) 0.75
Secondary syphilis after liver transplantation: case report and review of the literature. Clin Transplant (2006) 0.75
Correction to Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria. J Med Chem (2015) 0.75
S2k guideline* "Diagnosis and therapy of syphilis"--short version. J Dtsch Dermatol Ges (2015) 0.75
Challenges in the Development of a Thiol-Based Broad-Spectrum Inhibitor for Metallo-β-Lactamases. ACS Infect Dis (2017) 0.75
Multistep virtual screening for rapid and efficient identification of non-nucleoside bacterial thymidine kinase inhibitors. Chemistry (2010) 0.75
Brief communication: evidence of Bartonella quintana infections in skeletons of a historical mass grave in Kassel, Germany. Am J Phys Anthropol (2011) 0.75